Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Artificial Intelligence in Mammography Screening in Norway [NA]
An ongoing clinical trial in Norway is evaluating artificial intelligence-assisted mammography screening for breast cancer and is currently …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer [Phase 2]
Phase 2 window-of-opportunity trial assesses preoperative low-dose azacitidine in high-risk early-stage breast cancer; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Polyurethan Versus Non-polyurethan Covered Implants in Combination With Radiotherapy
A completed clinical trial compared polyurethane-coated implants with non-polyurethane-coated implants used in conjunction with radiotherapy…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: PreOperative Endocrine Therapy for Individualised Care With Abemaciclib [Phase 3]
A Phase 3 clinical trial evaluating preoperative endocrine therapy with abemaciclib for individualized care in breast cancer is currently ac…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) [Phase 4]
A Phase 4 clinical trial evaluating escalating doses of abemaciclib to maintain treatment intensity in breast cancer; the study is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) [Phase 2]
Phase 2 trial evaluating estradiol for ER-positive advanced/metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. [Phase 2]
Phase 2 clinical trial evaluating Prifetrastat (PF-07248144) in combination with Fulvestrant for HR+/HER2- breast cancer. The study is plann…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Prospective Clinical Study Investigating the Use of the Histolog Scanner for Intraoperative Assessment of Surgical Margins in Patients Undergoing Breast-conserving Surgery for Histologically Confirmed Breast Cancer. The Histolog Scanner Operates on the Principle of Confocal Microscop
A prospective clinical study is evaluating the Histolog Scanner for intraoperative assessment of surgical margins in breast-conserving surge…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer [Phase 1]
A Phase 1 trial of BL0175 Injection in postmenopausal women with HR-positive locally advanced or metastatic breast, ovarian, or endometrial …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition [NA]
A completed clinical trial evaluating sequential electronic health record-based interventions to increase genetic testing for hereditary bre…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients [Phase 3]
Phase 3 clinical trial update examining postmastectomy internal mammary nodal irradiation for high-risk breast cancer patients. The study is…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Abbreviated Breast MRI After Cancer Treatment
A University of Pennsylvania–sponsored clinical trial evaluating abbreviated breast MRI after cancer treatment has completed. The study focu…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating circulating tumor DNA as a predictive marker to guide an early treatment switch in metastatic breast cance…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Patient Care Outreach, Navigation, Technology and Support 2.0 [NA]
A clinical trial update for a UCSF study on patient care outreach, navigation, technology and support, currently recruiting with no phase sp…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer [Phase 3]
Phase 3 trial evaluating subcutaneous leuprolide acetate for ovarian suppression in breast cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer [Phase 2]
Update on the PRECISION trial, a Phase II study evaluating breast-conserving surgery without adjuvant radiotherapy for favorable-risk breast…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management [NA]
A completed clinical trial evaluating decongestive exercise and compression for breast cancer–related lymphedema.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
This completed prospective clinical trial examines the development of hypothyroidism following radiotherapy in patients with breast cancer. …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of a Decision Tool for People Considering Breast Reconstruction Surgery [NA]
Memorial Sloan Kettering Cancer Center is conducting a study to evaluate a decision tool for people considering breast reconstruction after …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Prevention of Alopecia in Patients With Localised Breast Cancer [NA]
This clinical trial aims to prevent chemotherapy-induced alopecia in patients with localized breast cancer and is currently recruiting.
-
CLINICAL_TRIALS other · 2026-01-13Clinical Trial Update: JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for JSKN016 in combination with D-0502 in HR-positive, HER2-negative metastatic or locally advanced breast…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery [Phase 3]
A Phase 3 randomized trial compares hypofractionated versus conventional radiotherapy after breast-conserving surgery for breast cancer, and…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastectomy [NA]
This clinical trial update describes evaluating fat grafting with a latissimus dorsi muscle flap for delayed breast reconstruction after mas…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)
Completed observational real-world study (BCARE) evaluating how dermatological toxicities from adjuvant endocrine therapy for early breast c…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer [Phase 3]
A Phase 3 trial update reports results for patient preference regarding home administration of a subcutaneous fixed-dose combination of pert…